Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OXYCODONE/ACET | 5MG 325MG | TABLET | Resolved | 2020-07-08 | 2020-09-21 | 119762 |
APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-08 | 2020-09-04 | 119765 |
APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2020-07-08 | 2020-08-21 | 119770 |
APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-08 | 2020-09-21 | 119773 |
APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2020-07-23 | 2021-05-17 | 120971 |
APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2020-07-23 | 2020-08-07 | 120979 |
APO-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-07-23 | 2020-11-16 | 120982 |
APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-23 | 2020-09-04 | 120985 |
APO-VARENICLINE | 1MG | TABLET | Resolved | 2020-07-23 | 2020-08-10 | 120988 |
ANAFRANIL | 25MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 121017 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2020-07-24 | 2021-01-19 | 121090 |
APO-LISINOPRIL | 20MG | TABLET | Resolved | 2020-07-29 | 2020-10-05 | 121328 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2020-07-29 | 2020-08-05 | 121331 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2020-07-29 | 2020-12-17 | 121334 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2020-07-29 | 2020-12-17 | 121337 |
APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2020-07-29 | 2020-09-04 | 121340 |
APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-29 | 2020-09-21 | 121343 |
APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2020-08-05 | 2020-09-14 | 121768 |
APO-METOPROLOL | 100MG | TABLET | Resolved | 2020-08-06 | 2020-11-09 | 121906 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2020-08-06 | 2020-10-05 | 121909 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |